Key facts
- Quai.MD’s last known valuation is $16.0M (Jan 2026).
- It has raised $5.4M; the latest was Later Stage VC ($8.0M) in Mar 2026.
- Notable investors include OurCrowd, Mayo Clinic, BIRD Foundation, Good Company (Israel), I-Next Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Quai.MD
- ·The full record, as it builds
Funding rounds
No funding rounds for Quai.MD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Quai.MD
Developer of a clinical decision support platform designed to assist physicians in real-time diagnostic processes. The company's platform integrates with electronic health records to provide personalized, evidence-based clinical pathways, automates documentation for improved billing efficiency, and offers real-time recommendations tailored to individual patient data, enabling healthcare providers to reduce unnecessary admissions, enhance diagnostic accuracy, and improve overall patient outcomes.
- Sector
- Healthcare
- HQ
- Neve Ilan, Israel
- Founded
- 2020
- Employees
- 25
- Website
- quai.md/
- Ownership
- Privately Held (backing)
Quai.MD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quai.MD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quai.MD in its N-PORT filings yet. We sweep new filings monthly.